I am honored to participate as a candidate for the 2020 Students of the Year program, a seven-week initiative in which select high school students from around the country participate in a fundraising competition to benefit The Leukemia & Lymphoma Society. I am proud to support LLS's mission and am raising critical dollars in honor of a young patient hero who is currently battling a blood cancer. Each dollar is a vote. The candidate team that raises the most money at the end of the seven weeks is named Student of the Year. Our mission is to not only raise the most money but also to bring attention to blood cancers like leukemia, which is the most common form of cancer in children and teens.

My team and I decided to call the team Team Brave because we want to acknowledge the incomprehendible bravery that cancer patients and their families must call on each day. When the outcome of treatment is uncertain, what is there to do but be brave? That thought is what makes me want to support LLS's mission. If Team Brave can help give even one person hope, we'll have succeeded. 

Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled or even quadrupled. And many LLS supported therapies not only help blood cancer patients but are helping patients with other cancers and serious diseases. In fact, drugs first approved for blood cancers are now approved to treat patients with stomach cancers, skin cancers, and autoimmune diseases like rheumatoid arthritis.

We really are changing the face of blood cancer!

All donations are greatly appreciated and are tax deductible. They'll not only support LLS-funded research but will help provide critical information and support for patients, and support advocacy for laws to ensure patients can access the care and treatments they need.

Please visit our website often and bring friends who would also like to donate!

On behalf of blood cancer patients everywhere, thank you for your support!

For more information about LLS, please visit www.lls.org.